| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9681 |
| Human Intestinal Absorption | HIA+ | 0.9974 |
| Caco-2 Permeability | Caco2+ | 0.8439 |
| P-glycoprotein Substrate | Non-substrate | 0.5894 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7860 |
| Non-inhibitor | 0.7991 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7363 |
| Distribution |
| Subcellular localization | Nucleus | 0.4904 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7530 |
| CYP450 2D6 Substrate | Substrate | 0.7840 |
| CYP450 3A4 Substrate | Substrate | 0.6704 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8593 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8945 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.6465 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7902 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8488 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8536 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9288 |
| Non-inhibitor | 0.7493 |
| AMES Toxicity | Non AMES toxic | 0.6540 |
| Carcinogens | Non-carcinogens | 0.9133 |
| Fish Toxicity | High FHMT | 0.5671 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9074 |
| Honey Bee Toxicity | High HBT | 0.6456 |
| Biodegradation | Not ready biodegradable | 0.9809 |
| Acute Oral Toxicity | II | 0.6112 |
| Carcinogenicity (Three-class) | Non-required | 0.6112 |